Resultados del grupo de estudio holandés en MEN-1
Alemtuzumab-Induced Thyroid Dysfunction Exhibits Distinctive Clinical and Immunological Features
Nadia Pariani, Mark Willis, Ilaria Muller, Sarah Healy,Taha Nasser, Anne McGowan,1 Greta Lyons, Joanne Jones, Krishna Chatterjee, Colin Dayan, Neil Robertson, Alasdair Coles and Carla Moran.
J Clin Endocrinol Metab 103: 3010–3018, 2018
Un ensayo aleatorizado, doble ciego, controlado con placebo, fase 3
Burosumab Therapy in Children with X-Linked Hypophosphatemia
Carpenter TO, et al. N Engl J Med. 2018 May 24;378(21):1987-1998
